TORONTO, ON-Bloom Burton & Co., a Canadian healthcare-specialized investment banking firm, has announced that it will host its inaugural Bloom Burton Award Gala at the Four Seasons Hotel in Toronto, ON on September 14, 2017.
As part of this special event, the firm also plans to recognize the most significant contributor to Canada’s Healthcare Industry with its newly minted ‘Bloom Burton Award.’
According to the firm, this award will be bestowed annually and will go to an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who has made the greatest impact in Canada’s innovative healthcare industry.
“It’s time to celebrate those who advance medical science, attract and provide risk capital, launch new products and companies on the world stage or announce significant monetization events,” Bloom Burton & Co president Brian Bloom said. “The Bloom Burton Award will celebrate today’s finest, who have made a significant impact – and there will be recognition for this contribution in the year it was achieved.”
Nominees will be accepted from the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, healthcare services or healthcare IT sectors, and from all therapeutic indications and stages of development.
The Bloom Burton Award winner will be chosen by an esteemed panel of judges, all of whom are respected international leaders in healthcare investment, entrepreneurship and journalism.
The judging panel includes:
-Karen Bernstein, Co-Founder and Chairman, BioCentury Inc.;
-Terrence Connolly, Executive Director, Global Alliances and Business Development, Celgene Corporation;
-Carl Gordon, Partner and Co-Head of Global Private Equity, OrbiMed Advisors;
-Andrew Hack, Chief Financial Officer, Editas Medicine;
-Oleg Nodelman, Founder and Managing Director, EcoR1 Capital;
-Melinda Richter, Head of Johnson & Johnson Innovation, JLABS; and
-Avik Roy, Opinion Editor, Forbes; President, The Foundation for Research and Equal Opportunity
Nominations may be submitted by the public at large on or before March 31, 2017. A narrowed list of three finalists will be announced at the Bloom Burton & Co. Healthcare Investor Conference, May 1-2, 2017. All three finalists, along with their family and friends, will be invited to and celebrated at the Bloom Burton Award Gala on September 14, 2017. The winner will receive a $50,000 cash price, while the other two finalists will each receive $25,000.
A limited number of tickets are available for industry sponsors and individuals; please visit www.bloomburton.com for more information.
ProMetic reacquires plasminogen rights from Hematech Next Post:
Feds fund DNAstack to build the Canadian Genomics Cloud